Barclays Issues Positive Forecast for DuPont de Nemours (NYSE:DD) Stock Price

Key Points

• Barclays raised its DuPont price target to $176 from $156 and reiterated an “overweight” rating, implying 13.52% upside from the prior close.
• Analyst views are mixed, but the consensus remains “Moderate Buy,” with an average price target of $163.25; 12 analysts rate the stock Buy, five Hold, and one Sell.
• DuPont beat quarterly earnings and revenue expectations, with EPS of $2.09 versus $1.87 expected and revenue up 4.1% year over year. The company also raised its 2026 outlook.

DuPont de Nemours (NYSE:DD - Get Free Report) had its price objective raised by stock analysts at Barclays from $156.00 to $176.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has an "overweight" rating on the basic materials company's stock. Barclays's target price indicates a potential upside of 13.52% from the company's previous close.

A number of other equities research analysts have also issued reports on the stock. JPMorgan Chase & Co. lowered shares of DuPont de Nemours from an "overweight" rating to a "neutral" rating and cut their target price for the company from $172.00 to $145.00 in a research note on Friday, October 9th. Weiss Ratings reissued a "sell (d+)" rating on shares of DuPont de Nemours in a report on Friday. UBS Group cut their price objective on DuPont de Nemours from $178.00 to $172.00 and set a "buy" rating on the stock in a research note on Monday, October 5th. Citigroup reduced their target price on DuPont de Nemours from $170.00 to $162.00 and set a "buy" rating on the stock in a report on Wednesday, October 7th. Finally, Zacks Research lowered DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 17th. Twelve analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, DuPont de Nemours has an average rating of "Moderate Buy" and an average price target of $163.25.

DuPont de Nemours Stock Up 1.0%

Shares of DD stock traded up $1.57 during mid-day trading on Wednesday, reaching $155.03. 870,396 shares of the company were exchanged, compared to its average volume of 1,342,499. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.82 and a current ratio of 2.43. The business's 50 day simple moving average is $132.64 and its 200 day simple moving average is $138.51. The company has a market capitalization of $20.94 billion, a P/E ratio of 345.12, a P/E/G ratio of 1.31 and a beta of 1.06. DuPont de Nemours has a fifty-two week low of $111.15 and a fifty-two week high of $157.98.

DuPont de Nemours (NYSE:DD - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.22. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The firm had revenue of $1.87 billion for the quarter, compared to analysts' expectations of $1.84 billion. During the same period in the prior year, the company posted $1.09 earnings per share. The firm's quarterly revenue was up 4.1% on a year-over-year basis. Research analysts predict that DuPont de Nemours will post 7.25 earnings per share for the current year.

Hedge Funds Weigh In On DuPont de Nemours

Several institutional investors have recently made changes to their positions in DD. AlphaCore Capital LLC grew its stake in DuPont de Nemours by 9.1% in the third quarter. AlphaCore Capital LLC now owns 7,382 shares of the basic materials company's stock valued at $959,000 after purchasing an additional 614 shares in the last quarter. Fulcrum Asset Management LLP raised its stake in shares of DuPont de Nemours by 44,056.2% during the 3rd quarter. Fulcrum Asset Management LLP now owns 7,065 shares of the basic materials company's stock worth $919,000 after purchasing an additional 7,049 shares in the last quarter. Missouri Trust & Investment Co raised its stake in shares of DuPont de Nemours by 17.6% during the 3rd quarter. Missouri Trust & Investment Co now owns 15,022 shares of the basic materials company's stock worth $1,952,000 after purchasing an additional 2,247 shares in the last quarter. Bryn Mawr Trust Advisors LLC lifted its holdings in shares of DuPont de Nemours by 1.2% during the 3rd quarter. Bryn Mawr Trust Advisors LLC now owns 19,125 shares of the basic materials company's stock valued at $2,484,000 after buying an additional 227 shares during the last quarter. Finally, Landmark Wealth Management LLC acquired a new stake in shares of DuPont de Nemours during the 3rd quarter valued at about $420,000. 73.96% of the stock is owned by institutional investors.

Key Stories Impacting DuPont de Nemours

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: Earnings and sales beat expectations. Q3 adjusted EPS was $2.09 versus analysts’ $1.87 estimate, while revenue of about $1.9 billion topped expectations and grew 4% year over year. DuPont also reported 5% organic sales growth. DuPont Reports Third Quarter 2026 Results
• Positive Sentiment: 2026 guidance was raised again. DuPont said results exceeded its Q3 guidance and lifted its full-year forecast, citing strength in healthcare and aerospace demand. The outlook increase supports expectations for continued earnings growth. DuPont raises full-year profit forecasts
• Positive Sentiment: Shareholder returns and cash generation were robust. The company reported $341 million in transaction-adjusted free cash flow, completed substantial repurchases in Q3, and intends to buy back another $250 million of shares in Q4. DD Q3 Earnings Beat on Organic Growth, Raises 2026 Outlook
• Positive Sentiment: A new peptide-purification product may broaden DuPont’s life-sciences opportunity. The product announcement adds a potential growth avenue, though the available report provides no sales or financial contribution estimates. What Is DuPont Signaling With Its New Peptide Purification Product?

About DuPont de Nemours

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company's product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.